Press Release 100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Capsule (UTD2) for the Treatment of Gastric Cancer SAN FRANCISCO, March 21, 2024 /PRNewswire/ — Biostar Pharma, Inc., the U.S. subsidiary… CISION PRNewswireMarch 21, 2024
Press Release Yeahka Announces 2023 Annual Results Brilliant growth momentum in one-stop payment services, GPV increased by 29.2% YoY,… CISION PRNewswireMarch 21, 2024
Press Release Aireon Signs Expanded Data Distribution Deal with Airbus for Space-Based ADS-B MCLEAN, Va., March 21, 2024 /PRNewswire/ — Aireon, the leader in space-based… CISION PRNewswireMarch 21, 2024
Press Release Compute for Climate Fellowship Announces Inaugural Winners and Opens Applications for 2024 The program funds proof of concepts for new ideas leveraging advanced cloud… CISION PRNewswireMarch 21, 2024
Press Release Borderless AI Launches from Stealth with $27M Investment to Bring World's First AI Agent to HR Space The company is building AI agents for the global HR industry, leveraging… CISION PRNewswireMarch 21, 2024
Press Release Compute for Climate Fellowship Announces Inaugural Winners and Opens Applications for 2024 The program funds proof of concepts for new ideas leveraging advanced cloud… CISION PRNewswireMarch 21, 2024
Press Release FDA Grants Orphan Drug Designation to Cevidoplenib for ITP PANGYO, South Korea, March 21, 2024 /PRNewswire/ — Oscotec Inc. has secured… CISION PRNewswireMarch 21, 2024
Press Release Henlius 2023 Annual Results: Revenue surpassed RMB5.39 billion with a net profit RMB546 million, first full-year profitability achieved SHANGHAI, March 21, 2024 /PRNewswire/ — Henlius (2696.HK) announced its 2023 annual… CISION PRNewswireMarch 21, 2024
